Despins P, Hutter J, Wallis J, Higenbottam T, Wallwork J
Clinique de chirurgie thoracique, cardiaque et vasculaire, CHU Nantes, Hôpital G. et R. Laënnec.
Arch Mal Coeur Vaiss. 1988 Apr;81(4):453-60.
Between April 5, 1984 and May 9, 1987, 24 patients underwent heart-lung transplantation for a variety of vascular and pulmonary diseases. Graft procurement being usually distant, the cardiopulmonary protection used was based on a simple hypothermic flush technique performed in donors prepared with prostacyclin. There was no primary graft deficiency and no intra-operative death. 17 patients are alive after a follow-up period of 1 to 41 months. The actuarial survival rate at 1 year was 77 p. 100. Late mortality was mainly due to cytomegalovirus infections. Immunosuppression relied on cyclosporine A and azathioprine with peri-operative use of antilymphocyte serum and corticosteroids. Early graft rejection episodes were treated with bolus intravenous methylprednisone. These episodes were detected from combined clinical, radiological, spirometric and histological data. Transbronchial lung biopsy was the reference examination for an objective diagnosis of lung rejection. In this series there was only one case of obliterative bronchiolitis (4 p. 100). This must be credited to the strategy used to detect rejection which seems to be the main factor of occurrence of this dangerous complication.
1984年4月5日至1987年5月9日期间,24例患者因各种血管和肺部疾病接受了心肺移植。由于供体获取通常距离较远,所采用的心肺保护措施基于一种简单的低温灌注技术,该技术在使用前列环素预处理的供体中进行。未出现原发性移植物功能不全,也没有术中死亡。17例患者在1至41个月的随访期后仍存活。1年时的精算生存率为77%。晚期死亡率主要归因于巨细胞病毒感染。免疫抑制依赖环孢素A和硫唑嘌呤,并在围手术期使用抗淋巴细胞血清和皮质类固醇。早期移植物排斥反应发作采用大剂量静脉注射甲基强的松龙治疗。这些发作通过综合临床、放射学、肺功能和组织学数据进行检测。经支气管肺活检是客观诊断肺部排斥反应的参考检查。在该系列中,仅出现1例闭塞性细支气管炎(4%)。这必须归功于用于检测排斥反应的策略,该策略似乎是这种危险并发症发生的主要因素。